PharmD_Rodriguez — that is really helpful context on SURMOUNT-MMO tirzepatide. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

To answer sophie_paris's question specifically:

From a clinical standpoint, SURMOUNT-MMO tirzepatide for is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

Thank you B12Beth! This is incredibly helpful. Bookmarking for later. 🙏

Relevant to SURMOUNT-MMO tirzepatide for — here is my latest bloodwork comparison:

Key improvements: A1C 7.6% → 5.5%, triglycerides 213 → 113 mg/dL, hsCRP 8.0 → 1.3 mg/L. All on tirzepatide for 17 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Slightly tangential to SURMOUNT-MMO tirzepatide but B12Beth reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.